Memantine oral NMDA receptor modulator: NTII began a Phase IIb dose-ranging trial

By WIR Staff | Nov 2, 1998 | 8:00 AM GMT

Neurobiological Technologies Inc. (NTII), Richmond, Calif.
Product: Memantine oral NMDA

Read the full 101 word article

How to gain access

Continue reading with a
two-week free trial.